• Application Note

Flunitrazepam

Flunitrazepam

  • Waters Corporation

This is an Application Brief and does not contain a detailed Experimental section.

Abstract

This application brief demonstrates analysis of flunitrazepam.

Introduction

The compound analyzed in this study is flunitrazepam (USP Tailing Factors - 1.2).

Experimental

HPLC Method

Column:

Symmetry C18, 3.9 x 150 mm, 5 μm

Part number:

WAT046980

Mobile phase:

50 mM potassium phosphate pH 6.0/acetonitrile 60:40

Flow rate:

1.0 mL/min

Injection volume:

10 μL of 30 μg/mL flunitrazepam

Detection:

UV @ 219 nm

Results and Discussion

Featured Products

WA31763.85, June 2003

Back To Top Back To Top